<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36-pharmaceuticals-13-00444">
 <label>36.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Süsskind</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Thürmann</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Lüke</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Jeschke</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Tabali</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Matthes</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ostermann</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Adverse drug reactions in a complementary medicine hospital: A prospective, intensified surveillance study</article-title>
  <source>Evidence-based Complement. Altern. Med.</source>
  <year>2012</year>
  <volume>2012</volume>
  <pub-id pub-id-type="doi">10.1155/2012/320760</pub-id>
  <?supplied-pmid 22315630?>
  <pub-id pub-id-type="pmid">22315630</pub-id>
 </element-citation>
</ref>
